EICHOR
● Completed
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects
Condition: Neurotrophic Keratitis · Sponsor: Claris Biotherapeutics, Inc.
About this study
This study will enroll subjects with stage 2 or 3 neurotrophic keratitis. Subjects will be randomized in a 1:1 ratio to the CSB-001 investigational treatment arm or vehicle control arm. All subjects will dose with the randomized treatment four times daily for 8 weeks (controlled treatment phase). During the controlled treatment phase, subjects will return to the clinic weekly from Day 0 to Week 8, and again at Week 10. Subjects randomized to the vehicle arm who are not healed will have the opportunity to participate in an open-label uncontrolled treatment phase.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (48)
| Eye Care North | Cave Creek, Arizona, United States | — |
| Loma Linda University Eye Institute | Loma Linda, California, United States | — |
| Nvision Clinical Research, LLC | Los Angeles, California, United States | — |
| Global Research Foundation | Los Angeles, California, United States | — |
| UCLA Stein Eye Institute | Los Angeles, California, United States | — |
| LoBue Laser and Eye Medical Center, Inc. | Murrieta, California, United States | — |
| California Eye Specialists Medical Group Inc. | Pasadena, California, United States | — |
| Martel Eye Medical Group | Rancho Cordova, California, United States | — |
| Gordon Schanzlin New Vision Institute | San Diego, California, United States | — |
| Atlantis Eyecare | Torrance, California, United States | — |
| University of Colorado - Dept. of Ophthalmology | Aurora, Colorado, United States | — |
| Vision Institute | Colorado Springs, Colorado, United States | — |
+ 36 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04909450